Marina Caskey to HIV-1
This is a "connection" page, showing publications Marina Caskey has written about HIV-1.
Connection Strength
1.117
-
Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic. Nat Med. 2019 04; 25(4):547-553.
Score: 0.263
-
Delivery of anti-HIV bNAbs by viral vectors. Lancet HIV. 2019 04; 6(4):e207-e208.
Score: 0.262
-
Broadly neutralizing antibodies for treatment and prevention of HIV-1 infection. Curr Opin HIV AIDS. 2018 07; 13(4):366-373.
Score: 0.250
-
Relationship between intact HIV-1 proviruses in circulating CD4+ T cells and rebound viruses emerging during treatment interruption. Proc Natl Acad Sci U S A. 2018 11 27; 115(48):E11341-E11348.
Score: 0.064
-
Combination therapy with anti-HIV-1 antibodies maintains viral suppression. Nature. 2018 09; 561(7724):479-484.
Score: 0.063
-
Relationship between latent and rebound viruses in a clinical trial of anti-HIV-1 antibody 3BNC117. J Exp Med. 2018 09 03; 215(9):2311-2324.
Score: 0.063
-
Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Clade B Clinical Isolates Produced in Peripheral Blood Mononuclear Cells. J Virol. 2018 03 01; 92(5).
Score: 0.061
-
Antibody 10-1074 suppresses viremia in HIV-1-infected individuals. Nat Med. 2017 Feb; 23(2):185-191.
Score: 0.056
-
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses. J Exp Med. 2020 11 02; 217(11).
Score: 0.018
-
Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals. Nat Med. 2018 11; 24(11):1701-1707.
Score: 0.016